Ann Taber

2.0k total citations
5 papers, 158 citations indexed

About

Ann Taber is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Ann Taber has authored 5 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Ann Taber's work include Urinary and Genital Oncology Studies (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ann Taber is often cited by papers focused on Urinary and Genital Oncology Studies (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ann Taber collaborates with scholars based in Denmark, United States and Austria. Ann Taber's co-authors include Jørgen Bjerggaard Jensen, Lars Dyrskjøt, Frederik Prip, Mads Agerbæk, Philippe Lamy, Torben Steiniche, Trine Line Hauge Okholm, Jakob Skou Pedersen, Emil Christensen and Sia V. Lindskrog and has published in prestigious journals such as Nature Communications, iScience and Urologic Oncology Seminars and Original Investigations.

In The Last Decade

Ann Taber

4 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Taber Denmark	3	121	63	44	38	21	5	158
Daniel Oyón United States	4	130 1.1×	97 1.5×	30 0.7×	42 1.1×	29 1.4×	12	178
P. Céliz Spain	3	87 0.7×	36 0.6×	33 0.8×	41 1.1×	21 1.0×	7	126
Frederik Prip Denmark	7	196 1.6×	113 1.8×	69 1.6×	55 1.4×	45 2.1×	8	257
Trine Strandgaard Denmark	7	94 0.8×	57 0.9×	35 0.8×	26 0.7×	50 2.4×	12	146
Viraj Degaonkar United States	7	124 1.0×	23 0.4×	43 1.0×	116 3.1×	36 1.7×	9	200
Pradeep Bose United Kingdom	5	36 0.3×	36 0.6×	38 0.9×	37 1.0×	17 0.8×	6	111
Maciej Oszczudłowski Poland	5	156 1.3×	131 2.1×	74 1.7×	58 1.5×	84 4.0×	14	291
Ann Taber Denmark	2	122 1.0×	37 0.6×	63 1.4×	38 1.0×	89 4.2×	3	158
David Darling New Zealand	7	274 2.3×	75 1.2×	54 1.2×	33 0.9×	28 1.3×	12	293
Anouk E. Hentschel Netherlands	7	112 0.9×	107 1.7×	34 0.8×	19 0.5×	69 3.3×	13	182

Countries citing papers authored by Ann Taber

Since Specialization

Citations

This map shows the geographic impact of Ann Taber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Taber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Taber more than expected).

Fields of papers citing papers by Ann Taber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Taber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Taber. The network helps show where Ann Taber may publish in the future.

Co-authorship network of co-authors of Ann Taber

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Taber. A scholar is included among the top collaborators of Ann Taber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Taber. Ann Taber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Anurag, Meenakshi, Trine Strandgaard, Sung Han Kim, et al.. (2024). Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics. iScience. 27(3). 109179–109179. 2 indexed citations

2.

Taber, Ann, Frederik Prip, Philippe Lamy, et al.. (2022). Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer. European Urology Oncology. 5(2). 203–213. 9 indexed citations

3.

Taber, Ann, Frederik Prip, Jerry Xiao, et al.. (2021). STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 39(7). 438.e1–438.e9. 12 indexed citations

4.

Taber, Ann, Emil Christensen, Philippe Lamy, et al.. (2020). Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nature Communications. 11(1). 4858–4858. 135 indexed citations

5.

Taber, Ann, Emil Christensen, Philippe Lamy, et al.. (2020). Molecular Correlates of Cisplatin-based Chemotherapy Response in Muscle Invasive Bladder Cancer by Integrated Multi-omics Analysis. Urologic Oncology Seminars and Original Investigations. 38(12). 899–899.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact